Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Microbot Medical ( (MBOT) ).
On September 29, 2025, Microbot Medical Inc. announced that a holder exercised 600,000 series H preferred investment options for common stock, receiving new series J options as part of a previously-disclosed inducement agreement. Additionally, the company issued 30,000 preferred investment options to H.C. Wainwright & Co., LLC, with the remaining options expected to be exercised by October 15, 2025. Earlier, on September 23, 2025, Microbot Medical issued 374,167 shares of common stock from the exercise of preferred investment options, generating approximately $896,000 in gross proceeds.
The most recent analyst rating on (MBOT) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Microbot Medical stock, see the MBOT Stock Forecast page.
More about Microbot Medical
Microbot Medical Inc. is a company operating in the medical industry, focusing on developing innovative robotic medical technologies and devices.
Average Trading Volume: 4,099,960
Technical Sentiment Signal: Buy
Current Market Cap: $144.4M
For detailed information about MBOT stock, go to TipRanks’ Stock Analysis page.